Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
va111913 (1 trial)
devimistat (1 trial)
Dysmenorrhea (Phase 2)
Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (2 total)